Camlin Fine Sciences has informed that pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), the schedule of Analyst or Investor Meeting(s) to discuss about the Company’s business and about the industry is as enclosed.
The above information is a part of company’s filings submitted to BSE.